Health and Fitness Health and Fitness
Thu, August 5, 2010
[ Thu, Aug 05th 2010 ] - Market Wire
Targacept Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
Bioject Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
MannKind to Present at the 30th Annual Canaccord Genuity Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
Ramius Highlights Concerns Regarding Recent Trans .. otion With Forest Laboratories Without First Expl
[ Thu, Aug 05th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. t 30th Annual Canaccord Genuity Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
Aeterna Zentaris Announces NIH Grant for a Phase .. 2 Study in Advanced Prostate Cancer with AEZS-108
[ Thu, Aug 05th 2010 ] - Market Wire
YM BioSciences announces conclusion of Phase I do .. nsion of ongoing CYT387 Phase I/II clinical study
[ Thu, Aug 05th 2010 ] - Market Wire
Quidel to Present at Canaccord Genuity 30th Annual Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
FDA Approves New Taxotere® (docetaxel) Injection Concentrate Formulation
Wed, August 4, 2010
[ Wed, Aug 04th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Report Second Quarter .. d Conduct Conference Call on Wednesday, August 11
[ Wed, Aug 04th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the Canaccord Genuity 30th Annual Global Growth Conference
[ Wed, Aug 04th 2010 ] - Market Wire
Orthofix International to Participate in Canaccord Genuity Growth Conference
[ Wed, Aug 04th 2010 ] - Market Wire
Abiomed Reports Record U.S. Impella Utilization for First Quarter of Fiscal 2011
[ Wed, Aug 04th 2010 ] - Market Wire
Celldex Reports Second Quarter 2010 Financial Results
[ Wed, Aug 04th 2010 ] - Market Wire
Aeterna Zentaris to Announce Second Quarter 2010 .. inancial and Operating Results on August 12, 2010
[ Wed, Aug 04th 2010 ] - Market Wire
Lux Biosciences receives Complete Response letter from FDA for voclosporin
[ Wed, Aug 04th 2010 ] - Market Wire
Teleflex Prices Offering of $350 Million Convertible Senior Subordinated Notes Due 2017
[ Wed, Aug 04th 2010 ] - Market Wire
Concerned Osteotech Stockholders Announce Nominat .. bers to the Board of Directors of Osteotech, Inc.
[ Wed, Aug 04th 2010 ] - Market Wire
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend to Shareholders
[ Wed, Aug 04th 2010 ] - Market Wire
Theragenics to Report Second Quarter 2010 Financial Results Tuesday, August 10
[ Wed, Aug 04th 2010 ] - Market Wire
Tenet Announces Pricing of Its Private Offering of Senior Notes due 2020
[ Wed, Aug 04th 2010 ] - Market Wire
ZymoGenetics to Webcast Presentation at the Canaccord Annual Growth Conference
Tue, August 3, 2010
[ Tue, Aug 03rd 2010 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Almost Family, Inc.
[ Tue, Aug 03rd 2010 ] - Market Wire
Humana Military Healthcare Services Named in the .. for Military Times 2010 aBest Employers for Vetsa
[ Tue, Aug 03rd 2010 ] - Market Wire
Neurocrine Biosciences, Big 5 Sporting Goods, Aetna, CVS Caremark and Express Scripts
[ Tue, Aug 03rd 2010 ] - Market Wire
Humana, Unitedhealth, Allergan, Medicis Pharma and Johnson & Johnson
[ Tue, Aug 03rd 2010 ] - Market Wire
Enzon Reports Second Quarter 2010 Results
[ Tue, Aug 03rd 2010 ] - Market Wire
Five Prime Therapeutics, Inc. Announces Strategic .. e to Discover Innovative Biologics for Skeletal M
[ Tue, Aug 03rd 2010 ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth Conference
[ Tue, Aug 03rd 2010 ] - Market Wire
Array BioPharma to Report Financial Results for t .. er and Full Year of Fiscal 2010 on August 9, 2010

Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2010 on August 9, 2010


Published on 2010-08-03 13:36:23 - Market Wire
  Print publication without navigation


BOULDER, Colo.--([ BUSINESS WIRE ])--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2010 on Monday, August 9, 2010, and will hold a conference call on Tuesday, August 10, 2010 at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information

Date:

 Tuesday, August 10, 2010

Time:

 9:00 a.m. eastern time

Toll-Free:

 888-280-4443

Toll:

 719-325-2392

Pass Code:

 6859246

Web Cast:

[ www.arraybiopharma.com ]

A replay of the call will be available as a webcast on [ www.arraybiopharma.com ] and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 6859246.

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to [ www.arraybiopharma.com ].

Contributing Sources